CLINICAL_TRIALS
trial_result
· 2025-02-10
Clinical Trial Update: Evaluation of SAR408701 in Patients With Advanced Solid Tumors [Phase 1]
Summary
This Phase 1 trial evaluated SAR408701 in patients with advanced solid tumors. The study status is terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Neoplasm Malignant | Phase 1 | Status: TERMINATED